Association of a polymorphism of BTN2A1 with dyslipidemia in East Asian populations by �옣�뼇�닔
EXPERIMENTAL AND THERAPEUTIC MEDICINE  2:  745-749,  2011
Abstract. We previously identified rs6929846 of the 
butyrophilin, subfamily 2, member A1 gene (BTN2A1) as a 
susceptibility locus for myocardial infarction in Japanese 
individuals by a genome-wide association study. The aim 
of the present study was to examine the relation of the 
rs6929846 polymorphism of BTN2A1 to dyslipidemia in 
Japanese and Korean populations, given that dyslipidemia 
is an important risk factor for myocardial infarction. A total 
of 10,953 individuals from three independent subject panels 
were examined. The relations of the rs6929846 polymor-
phism of BTN2A1 to serum concentrations of triglycerides, 
high-density lipoprotein (HDL)-cholesterol and low-density 
lipoprotein (LDL)-cholesterol were examined in each subject 
panel. The C→T polymorphism (rs6929846) of BTN2A1 
was significantly associated with serum concentrations of 
triglycerides in Japanese subject panels A (P=0.0004) and B 
(P=0.0010), and in the Korean population (P=0.0095), 
with the minor T allele being related to an increased serum 
concentration of triglycerides. The rs6929846 was associated 
with serum concentrations of HDL-cholesterol in Japanese 
subject panels A (P=0.0047) and B (P=0.0015), with the 
T allele being related to a decreased serum concentration of 
HDL-cholesterol, but not in the Korean population. This poly-
morphism was associated with the serum concentration of 
LDL-cholesterol only in Japanese subject panel B (P=0.0059), 
with the T allele being related to an increased serum concen-
tration of LDL-cholesterol. The results suggest that BTN2A1 
may be a susceptibility gene for hypertriglyceridemia in East 
Asian populations and for low serum HDL-cholesterol in the 
Japanese population.
Introduction
Dyslipidemia is a multifactorial disorder caused by an inter-
action between genetic and environmental factors, the latter 
including a high-fat and high-calorie diet and physical inac-
tivity (1,2). Although recent genome-wide association studies 
(GWASs) have implicated several loci and candidate genes 
in predisposition to dyslipidemia in Caucasian populations 
(3-5), the genes that confer susceptibility to this condition 
in Asian populations remain to be identified definitively. We 
previously showed that the C→T polymorphism (rs6929846) 
of the butyrophilin, subfamily 2, member A1 gene (BTN2A1) 
is significantly associated with the prevalence of myocardial 
infarction in Japanese individuals by a GWAS (6). Given that 
dyslipidemia is an important risk factor for myocardial infarc-
tion, we hypothesized that the association of rs6929846 with 
myocardial infarction may be attributable, at least in part, to 
its effect on susceptibility to dyslipidemia. We thus examined 
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the relation of rs6929846 of BTN2A1 to dyslipidemia in 
Japanese and Korean populations.
Patients and methods
Study population. A total of 10,953 Japanese or Korean indi-
viduals from three independent subject panels was examined. 
The Japanese subject panel A comprised 3,319 individuals 
who either visited outpatient clinics of or were admitted to 
participating hospitals (Gifu Prefectural General Medical 
Center, Gifu; and Hirosaki University Hospital and Hirosaki 
Stroke Center, Hirosaki, Japan) between October 2002 and 
March 2009 because of various symptoms or for an annual 
health checkup. The Japanese subject panel B comprised 
4,297 individuals who either visited outpatient clinics of or 
were admitted to participating hospitals (Gifu Prefectural 
Tajimi Hospital, Tajimi; Japanese Red Cross Nagoya First 
Hospital, Nagoya; and Inabe General Hospital, Inabe, Japan) 
between October 2002 and March 2009, or who were 
recruited to population-based cohort studies of aging and 
age-related diseases in Nakanojo, Kusatsu and Tokyo, Japan. 
The study protocol complied with the Declaration of Helsinki 
and was approved by the Committees on the Ethics of Human 
Research of Mie University Graduate School of Medicine, 
Hirosaki University Graduate School of Medicine, Gifu 
International Institute of Biotechnology, Tokyo Metropolitan 
Institute of Gerontology and participating hospitals. Written 
informed consent was obtained from each subject.
A total of 3,337 Korean subjects was drawn from the 
institutional patient databases of the Cardiovascular Genome 
Center and the Infarction Prognosis Study Registry, Severance 
Cardiovascular Hospital, Seoul. The study protocol complied 
with the Guidelines for Genome/Genetic Research issued by 
the Korean government and was approved by the Institutional 
Review Board of Yonsei University. Written informed consent 
was obtained from each participant.
Measurement of serum lipid profile. Venous blood was 
collected in the early morning after the subjects had fasted 
overnight and before they had begun lipid-lowering treat-
ment as appropriate. Blood samples were centrifuged at 
1,600 x g for 15 min at 4˚C, and serum was separated and 
stored at -30˚C until analysis. The serum concentrations of 
triglycerides, high-density lipoprotein (HDL)-cholesterol and 
low-density lipoprotein (LDL)-cholesterol were measured as 
previously described (7).
Genotyping of rs6929846 of BTN2A1. For Japanese indi-
viduals, venous blood (7 ml) was collected into tubes 
containing ethylenediaminetetraacetic acid (disodium salt) 
at a final concentration of 50 mmol/l, and genomic DNA 
was isolated with a kit (Genomix; Talent, Trieste, Italy). 
Genotype of rs6929846 of BTN2A1 was determined at G&G 
Science (Fukushima, Japan) by a method that combines the 
polymerase chain reaction (PCR) and sequence-specific 
oligonucleotide probes with suspension array technology 
(Luminex, Austin, TX, USA). Genotyping involved PCR 
amplification, hybridization, streptavidin-phycoerythrin reac-
tion and measurement of fluorescence. Detailed genotyping 
methodology was described previously (6,8).
For Korean subjects, genomic DNA was extracted from 
5 ml of whole blood with the use of a DNA isolation kit 
(WIZARD Genomic DNA purification kit; Promega, Madison, 
WI, USA). Genotype of rs6929846 was determined with 
the use of a TaqMan fluorogenic 5' nuclease assay (Applied 
Biosystems, Foster City, CA, USA). The PCR mixture (final 
volume, 5 µl) contained 2 ng of genomic DNA, 2.5 µl of 
TaqMan Universal PCR Master Mix and 0.125 µl (or 0.25 µl) 
of 40X (or 20X) Assay Mix. The mixture was incubated first 
at 50˚C for 2 min to activate uracil N-glycosylase and to 
prevent carryover contamination, and then at 95˚C for 10 min 
to activate DNA polymerase; it was subsequently subjected 
to 40 cycles of incubation at 92˚C for 15 sec and 60˚C for 
1 min. All reactions were performed in 384-well plates with 
the use of a Dual 384-Well GeneAmp PCR System 9700 
(Applied Biosystems), and endpoint fluorescence readings 
were performed with a PRISM 7900 HT Sequence Detection 
System (Applied Biosystems). Duplicate samples and negative 
controls were included to ensure accuracy of genotyping (6).
Statistical analysis. Quantitative data were compared between 
two groups by the unpaired Student's t-test. The Chi-square 
test was used to identify departures from Hardy-Weinberg 
equilibrium. A P-value of <0.05 was considered statistically 
significant. Statistical significance was examined by two-
sided test performed with JMP Genomics version 3.2 software 
(SAS Institute, Cary, NC, USA).
Results
The characteristics of the 10,953 subjects enrolled in the 
present study are shown in Table I. The prevalence of hyper-
triglyceridemia (a serum concentration of triglycerides of 
≥1.65 mmol/l), low-serum HDL-cholesterol (a serum concen-
tration of HDL-cholesterol of <1.04 mmol/l) and high-serum 
LDL-cholesterol (a serum concentration of LDL-cholesterol 
of ≥3.64 mmol/l) was 32.0, 21.6 and 25.7%, respectively, in 
Japanese subject panel A; 37.0, 16.2 and 21.9%, respectively, 
in Japanese subject panel B; and 28.0, 28.4 and 19.5%, respec-
tively, in the Korean population.
The relations of the BTN2A1 genotype to serum concen-
trations of triglycerides, HDL-cholestrol and LDL-cholesterol 
are shown in Table II. The C→T polymorphism (rs6929846) 
of BTN2A1 was significantly (P<0.05) associated with the 
serum concentrations of triglycerides in Japanese subject 
panels A (dominant and recessive models) and B (dominant 
model), and in the Korean population (recessive model), 
with the minor T allele being related to an increased serum 
concentration of triglycerides. The rs6929846 of BTN2A1 
was significantly associated with the serum concentrations 
of HDL-cholesterol in the Japanese subject panels A and 
B (dominant model), with the T allele being related to a 
decreased serum HDL-cholesterol, but not in the Korean 
population. The rs6929846 of BTN2A1 was significantly 
associated with the serum concentrations of LDL-cholesterol 
in the Japanese subject panel B (recessive model), with the 
T allele being related to an increased serum concentration of 
LDL-cholesterol, but not in the Japanese subject panel A or 
in the Korean population. In all Japanese and Korean indi-
viduals, rs6929846 of BTN2A1 was significantly associated 
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with serum concentrations of triglycerides (dominant and 
recessive models), HDL-cholesterol (dominant model) and 
LDL-cholesterol (recessive model). Genotype distributions in 
the Japanese subject panels A and B and in the Korean popu-
lation were all in Hardy-Weinberg equilibrium (Table II).
Discussion
Given that genetic factors and interactions between multiple 
genes and environmental factors are important in common 
forms of dyslipidemia (9), prediction of the risk for dyslipid-
emia on the basis of genetic variants would be beneficial for 
personalized prevention of this condition. We now showed 
that the T allele of rs6929846 in BTN2A1 was significantly 
associated with hypertriglyceridemia in Japanese and 
Korean populations, and with low-serum concentrations of 
HDL-cholesterol in Japanese individuals.
BTN2A1 is a member of the cluster of butyrophilin genes 
(BTNs) (10). BTNs are type I membrane glycoproteins that 
were initially identified in bovine milk fat globules (11). 
BTNs are located at the extended major histocompatibility 
complex region in chromosome 6, constitute the immu-
noglobulin superfamily together with the B7 gene family 
and butyrophilin-like gene (BTNL) family, and are widely 
expressed in a variety of human immune cells, suggesting a 
possible role in immune functions (12). Previous studies have 
shown significant relations of polymorphisms of BTNL2 with 
Kawasaki disease in Taiwanese children (13) and sarcoid-
osis in German (14) and American (15) populations, both of 
which are caused by inflammatory autoimmune responses. 
We previously showed that the T allele of rs6929846 was 
associated with an increased risk for myocardial infarction 
as well as with an increased transcription activity of BTN2A1 
(6). Overexpression of BTN2A1 decreased the expression of 
elastin mRNA and increased the mRNA expression of matrix 
metallopeptidase 3 and interleukin-5. In our preliminary 
experiment, the serum concentrations of high-sensitivity 
C-reactive protein were significantly greater in individuals in 
the combined group of CT and TT genotypes for rs6929846 of 
BTN2A1 than in those with the CC genotype in 755 healthy 
individuals without neoplastic, infectious or inflammatory 
disease (unpublished data). These observations suggest that 
the T allele of rs6929846 of BTN2A1 may accelerate inflam-
matory processes.
Inflammation is a key component of the regulation of 
lipid metabolism in rodents and primates (16). Inflammatory 
conditions under bacterial or viral infections were found to 
result in an increase in the serum concentration of triglyc-
erides and a decrease in the serum HDL-cholesterol in 
humans (17,18). Multiple cytokines are likely to affect the 
metabolism of cholesterol or triglycerides through several 
pathways, including the increased production and decreased 
clearance of very low-density lipoproteins, impaired reverse 
cholesterol transport and decreased excretion of bile acids 
(16,19-21). We now showed that rs6929846 of BTN2A1 was 
significantly associated with hypertriglyceridemia in Japanese 
and Korean populations and with reduced serum concentra-
tions of HDL-cholesterol in Japanese individuals, with the 
minor T allele representing a risk factor for these conditions. 
Acceleration of the inflammatory process by the T allele of 
Table I. Characteristics of the 10,953 study subjects.
Characteristics Japanese population Korean population
 --------------------------------------------------------------------------------------
 Subject panel A Subject panel B
No. of subjects 3,319 4,297 3,337
Age (years)   65.1±11.40 68.8±8.90   59.6±10.30
Gender (male/female, %) 57.5/42.5 58.3/41.7 68.1/31.90
Body mass index (kg/m2) 23.6±3.30 23.5±3.40 24.3±3.00
Current of former smoker (%) 19.8 36.9 53.4
Hypertension (%) 61.5 67.3 65.0
Diabetes mellitus (%) 31.3 38.0 19.6
Serum total cholesterol (mmol/l) 5.15±1.00 5.17±0.98 4.77±1.02
Hypercholesterolemia (%) 27.1 28.7 18.2
Serum triglycerides (mmol/l) 1.58±1.12 1.68±1.12 1.49±0.98
Hypertriglyceridemia (%) 32.0 37.0 28.0
Serum HDL-cholesterol (mmol/l) 1.35±0.41 1.40±0.40 1.26±0.37
Low HDL-cholesterol (%) 21.6 16.2 28.4
Serum LDL-cholesterol (mmol/l) 3.11±0.88 3.01±0.87 2.85±0.91
High LDL-cholesterol (%) 25.7 21.9 19.5
Data for age, body mass index and serum lipid concentrations are the means ± SD. Hypertension: systolic blood pressure of ≥140 mmHg, 
diastolic blood pressure of ≥90 mmHg or taking antihypertensive medication. Diabetes mellitus: fasting plasma glucose level of ≥6.93 mmol/l, 
blood glycosylated hemoglobin content of ≥6.5% or taking antidiabetes medication. Hypercholesterolemia: a serum concentration of total 
cholesterol of ≥5.69 mmol/l. Hypertriglyceridemia: a serum concentration of triglycerides of ≥1.65 mmol/l. Low HDL-cholesterol: a serum 
concentration of HDL-cholesterol of <1.04 mmol/l. High LDL-cholesterol: a serum concentration of LDL-cholesterol of ≥3.64 mmol/l.
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rs6929846 may result in alterations in lipid metabolism, 
although the underlying mechanism remains unknown.
There are limitations to the present study. i) Given that the 
study subjects were comprised only of Japanese and Korean 
individuals, validation of our findings is required in other 
ethnic groups. ii) It is possible that rs6929846 of BTN2A1 is in 
linkage disequilibrium with other polymorphisms in BTN2A1 
or in other nearby genes that are actually responsible for the 
development of dyslipidemia. iii) The functional relevance of 
rs6929846 of BTN2A1 to the pathogenesis of dyslipidemia 
remains unknown. iv) Finally, environmental factors, such as 
dietary habits, that influence lipid metabolism were not evalu-
ated in the present study.
In conclusion, BTN2A1 may be a susceptibility gene 
for hypertriglyceridemia in East Asian populations and for 
low-serum HDL-cholesterol in the Japanese population. 
Determination of genotypes for this polymorphism may prove 
informative for the assessment of the genetic risk for dyslipid-
emia in East Asian populations.
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